U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07753317) titled 'Evaluation of Subgingival 1% Metformin Gel Versus 0.05% Zoledronate Gel as an Adjunct to MINST of Intrabony Defects in Controlled Type 2 DM' on Aug. 04.
Brief Summary: The present randomized placebo-controlled trial aims to evaluate and compare the clinical and radiographic efficacy of subgingivally delivered 0.05% zoledronate gel and 1% metformin gel as adjuncts to minimally invasive nonsurgical treatment of intrabony defects in patients with controlled type 2 diabetes mellitus and periodontitis.
Study Start Date: Aug. 07
Study Type: INTERVENTIONAL
Condition:
Controlled Type 2 Diabetic Patients With Periodontitis
Intervention: ...